Showing results (151-160 of 184) with videos related to

Sort By:
Pageof 19
Journal of the American Academy of Dermatology|July 18, 2024
Topical nanoencapsulated cannabidiol cream as an innovative strategy combating UV-A-induced nuclear and mitochondrial DNA injury: A pilot randomized clinical studyErika McCormick, Haowei Han, Sara Abdel Azim, et al.
Clinical Reviews in Allergy & Immunology|July 31, 2025
Factors Influencing Treatment Adherence in Chronic Spontaneous Urticaria: A Systematic ReviewAditya Joshi, Lauren Gawey, Muhammad Rahman, et al.
Otology & Neurotology : Official Publication of the American Otological Society, American Neurotology Society [And] European Academy of Otology and Neurotology|January 22, 2019
Cochlear FLAIR Signal Changes in Hearing Preservation Vestibular Schwannoma SurgeryNathan Chin-Yau Tu, Gabriela Bobarnac Dogaru, Polly Huang, et al.
Experimental Dermatology|September 20, 2023
Nano-encapsulated anandamide reduces inflammatory cytokines in vitro and lesion severity in a murine model of cutaneous lupus erythematosusErika T McCormick, Andrew Draganski, Samantha Chalmers, et al.
Journal of the Association for Research in Otolaryngology : JARO|August 7, 2020
The Genetics of Variation of the Wave 1 Amplitude of the Mouse Auditory Brainstem ResponseEly Cheikh Boussaty, Danielle Gillard, Joel Lavinsky, et al.
Drug Delivery|February 28, 2026
Lipid nanoparticles with aptamers enable targeted mRNA delivery to CD4⁺ T cellsShrey Shah, Meenakshi Ranasinghe, John Decker, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 18, 2002
Abnormal gene expression in cloned mice derived from embryonic stem cell and cumulus cell nucleiDavid Humpherys, Kevin Eggan, Hidenori Akutsu, et al.
Virulence|May 18, 2011
Susceptibility of Gram-positive and -negative bacteria to novel nitric oxide-releasing nanoparticle technologyAdam Friedman, Karin Blecher, David Sanchez, et al.
Virulence|January 31, 2012
Nitric oxide nanoparticles: pre-clinical utility as a therapeutic for intramuscular abscessesDavid Schairer, Luis R Martinez, Karin Blecher, et al.
Canadian Journal of Diabetes|April 12, 2026
Preferred GLP-1 Receptor Agonists in Type 2 Diabetes With Established Cardiovascular Disease or High Cardiovascular Risk: A Network Meta-Analysis of Randomized TrialsMustafa Abomohsen, Mohamed Rifai, Ahmed Farid Gadelmawla, et al.
Pageof 19